Last reviewed · How we verify

NCT03472222

Arsha Vidya Program for Preventing Drug Abuse Among Disadvantaged Children in Urban Slums

Completed NA Last updated 24 May 2019
What this trial tests

NA trial testing Arsha Vidya program in Drug Abuse in 120 participants. Completed in 6 September 2018.

Timeline
21 February 2018
Primary endpoint
30 August 2018
6 September 2018

Quick facts

Lead sponsorNMP Medical Research Institute
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment120
Start date21 February 2018
Primary completion30 August 2018
Estimated completion6 September 2018
Sites1 location across India

Drugs / interventions tested

Conditions studied

Sponsor

NMP Medical Research Institute

Who can join

Adults 7 to 13, any sex, with Drug Abuse. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Substance abuse remain critical problems in both developed and developing countries. Under privileged communities where health and economic system is weakest, use of drugs and illicit substances starts during adolescence and young adulthood. This not just affect physical development, mental health and social integration, but also family formation and stability, deviant behaviour, sexual behaviour and involvement, educational pursuits, livelihood pursuits. Therefore, emphasises the need for preventive education at this impressionable age.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Drug Abuse

Currently open trials in the same condition.

Other NMP Medical Research Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03472222.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing